drugset / Trial / NCT04305691
Trial of Ixazomib for Kaposi Sarcoma
NaSingle-groupOpen-labelTreatment
Summary
This phase II trial studies how well ixazomib works in treating patients with Kaposi sarcoma. Ixazomib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Timeline
- Start
- 2023-11-07
- Primary completion
- 2029-03-15
- Completion
- 2029-03-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ixazomib | Unknown | — | Oral |